About this trial
The aim of this prospective, randomized, comparative, controlled clinical study is to compare laryngeal mask airway ProtectorTM with the endotracheal tube, regarding to the respiratory mechanical parameters during controlled mechanical ventilation and the prevalence of aspiration. Aspiration will be evaluated by detecting and quantifying pepsin (a marker of gastric aspiration) and α-amylase (a marker of salivary aspiration) in the bronchoalveolar lavage ( mini BAL) of patients ≥18 years old, ASA 1-2, undergoing selective low-risk surgery under general anesthesia in a lithotomy position.
Eligibility criteria
Qualifiers
Patients aged ≥18 years ASA1-2 who are to undergo planned urological surgery of low or intermediate severity, under general anesthesia in the lithotomy position.
Disqualifiers
patients < 18 years old.
Patients who are going to undergo an emergency/urgent operation/ trauma patients.
Maternal population.
Patients who are not scheduled to receive general anesthesia, but some other type of anesthesia.
Trial design
Treatments tested in this trial
- LMA Protector
- Endotracheal tube